Abbott has received FDA approval for a new lower-strength tablet formulation of its leading HIV protease inhibitor
Ads by Google
U.S. and Zambian officials recently signed a statement of collaboration with eight tourism companies to increase efforts to fight HIV/AIDS in Zambia.
Ohio Department of Education to apply for a $1.25 million grant intended to prevent the spread of HIV among teenagers.
People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen.
A campaign on the social networking Web site Facebook to cut tax rates on condoms in an effort to curb increasing HIV/AIDS rates in Europe.
Circumcision should not be promoted as a way to prevent HIV transmission because it could encourage recklessness among youth.
PlusNews examined HIV programs for people over the age of 50 in Africa.
The strategy of eliminating cells that display a distress signal when they are infected with HIV might lead to the development of a new HIV vaccine candidate.
HIV-positive women who are pregnant and receive the antiretrovirals tenofovir and emtricitabine during childbirth could reduce the risk of developing resistance to antiretroviral drugs.
Merck's experimental HIV vaccine was ineffective among some trial participants with a pre-existing immunity to a common cold virus and might have increased their susceptibility to HIV infection.
A type of infrared laser technology could be used to protect the human immune system against HIV, as well as other viruses and infections.
The number of HIV/AIDS cases on mainland China increased by an average of 3,000 monthly between January 2006 and June 2007, Wang Ning, deputy director of the Chinese Center for Disease Control and Prevention, said Monday, China Daily reports.
Washington Post examined reaction to a recent study that found that HIV likely arrived in the U.S. from Haiti about a decade earlier than previously believed.
IRIN News examined how HIV/AIDS and food shortages in Southern Africa are "reinforcing each other."
The HIV/TB co-epidemic rapidly is spreading in sub-Saharan Africa, where the threat of the two diseases largely has gone unnoticed.
Some epidemiologists, physicians and scientists have begun to "shift attention away from technological fixes," such as vaccines, to prevent HIV transmission toward "proven, lower-tech strategies," after Merck's experimental vaccine trial was halted in September, the Washington Post reports (Timberg, Washington Post, 11/1).
World Food Programme hopes to raise $103 million for a relief program in Malawi aimed at people affected by HIV/AIDS.
The most widespread HIV subtype outside Africa likely emerged in Haiti in the 1960s and arrived in the U.S. a few years later -- about 10 years earlier than previously believed.
Hillary Rodham Clinton signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide.
Some HIV-positive people in key demographic groups do not seek treatment any sooner than they did in the past, and some people now take longer to initiate treatment.
Nearly one-third of people living with tuberculosis in the U.S. are unaware of their HIV status.
Zimbabwe could meet its target of providing 140,000 HIV-positive people with access to no-cost antiretroviral drugs by the end of the year.
Researchers have asked people who participated in a trial of Merck's experimental HIV vaccine to undergo additional testing to determine if they are at an increased risk of HIV.
Senator Hillary Clinton pledged that, if elected US President, she will deliver on a range of bold, new policies to address global HIV/AIDS.
Efforts by police to stop injection drug use are undermining attempts to curb the spread of HIV among injection drug users in Southeast Asia.
Viral load-the amount of virus in the blood of an HIV-infected person-has long been viewed as the chief indicator of how quickly someone infected with HIV infection progresses to AIDS.